Parth Antibiotics Private Limited, a amalgamated private limited company, was established on 21 November 2009 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U51397MH2009PTC197201. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Devang Manharlal Ajmera (Director), Piyush Manharlal Ajmera (Director), Bhavin Manharlal Ajmera (Director). Its latest AGM occurred on 28 December 2020, with the balance sheet filed on 31 March 2020. It is based at 507,5Th Flr, Exim Link, Opp. Indira Container Yard Near Nahur Railway Station, Bhandup (Wes, T),, Mumbai, Maharashtra, 400078.
U51397MH2009PTC197201
197201
21 November 2009
₹0.50 M
₹0.10 M
Roc Mumbai
Unlisted
Amalgamated
Explore comprehensive insights into Parth Antibiotics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Devang Manharlal Ajmera | Director | 21 Nov 2009 | Current |
| Piyush Manharlal Ajmera | Director | 21 Nov 2009 | Current |
| Bhavin Manharlal Ajmera | Director | 21 Nov 2009 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Parth Antibiotics Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 64.43% increase. The company also saw a substantial improvement in profitability, with a 92.98% increase in profit. The company's net worth Soared by an impressive increase of 28.84%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Parth Antibiotics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Parth Antibiotics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Parth Antibiotics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Parth Antibiotics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Parth Antibiotics Private Limited last Annual general meeting of members was held on 28 Dec 2020 as per latest MCA records. was documented.
The activity Parth Antibiotics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Mumbai. was completed.
The activity Devang Manharlal Ajmera was appointed as a Director was appointed as a Director on 21 Nov 2009 & has been associated with this company since 16 years 1 month . was completed.
Progress on Piyush Manharlal Ajmera was appointed as a Director was appointed as a Director on 21 Nov 2009 & has been associated with this company since 16 years 1 month . was documented.
Bhavin Manharlal Ajmera was appointed as a Director was appointed as a Director on 21 Nov 2009 & has been associated with this company since 16 years 1 month . was recorded as a recent event.
Progress on Parth Antibiotics Private Limited was registered on 21 Nov 2009 with Roc Mumbai & aged 16 years 1 month as per MCA records. was documented.
The CIN of Parth Antibiotics Private Limited is U51397MH2009PTC197201.
Parth Antibiotics Private Limited is headquartered at 507,5Th Flr, Exim Link, Opp. Indira Container Yard Near Nahur Railway Station, Bhandup (Wes, T),, Mumbai, Maharashtra, 400078.
Parth Antibiotics Private Limited was incorporated on 21 November 2009.
The current directors of Parth Antibiotics Private Limited are
The primary industry of Parth Antibiotics Private Limited is Pharma.
Parth Antibiotics Private Limited is unlisted.
The authorized capital of Parth Antibiotics Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.
The compliance status of Parth Antibiotics Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX